As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for ...